Literature DB >> 17339440

Temporal dissection of T-bet functions.

Jennifer L Matsuda1, Thaddeus C George, James Hagman, Laurent Gapin.   

Abstract

T-bet is a transcription factor of the T-box family that regulates the expression of numerous immune system-associated genes. T-bet directs the acquisition of the Th1-associated genetic program in differentiating CD4(+) lymphocytes. It also influences the development of NK and NKT cells through its regulation of the IL-2/IL-15Rbeta-chain (CD122) and the trafficking of these lymphocytes through CxCR3. The temporal requirements of T-bet activity for the production of IFN-gamma and the regulation of CD122 and CxCR3 expression remain undefined. We produced an ectopically controllable form of T-bet by fusing its C-terminal domain with a mutated ligand-binding domain of human estrogen receptor alpha. By temporally controlling the expression of T-bet-estrogen receptor alpha by the addition or removal of 4-hydroxytamoxifen (4-HT), we show that IFN-gamma, CD122, and CxCR3 are direct gene targets of T-bet whose expression are acutely regulated by T-bet activity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17339440     DOI: 10.4049/jimmunol.178.6.3457

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  32 in total

1.  A central role for mTOR kinase in homeostatic proliferation induced CD8+ T cell memory and tumor immunity.

Authors:  Qingsheng Li; Rajesh R Rao; Koichi Araki; Kristen Pollizzi; Kunle Odunsi; Jonathan D Powell; Protul A Shrikant
Journal:  Immunity       Date:  2011-04-22       Impact factor: 31.745

2.  Interleukin-2-inducible T cell kinase (Itk) network edge dependence for the maturation of iNKT cell.

Authors:  Qian Qi; Mingcan Xia; Yuting Bai; Sanhong Yu; Margherita Cantorna; Avery August
Journal:  J Biol Chem       Date:  2010-10-29       Impact factor: 5.157

3.  Inflammation directs memory precursor and short-lived effector CD8(+) T cell fates via the graded expression of T-bet transcription factor.

Authors:  Nikhil S Joshi; Weiguo Cui; Anmol Chandele; Heung Kyu Lee; David R Urso; James Hagman; Laurent Gapin; Susan M Kaech
Journal:  Immunity       Date:  2007-08       Impact factor: 31.745

Review 4.  Multispectral imaging of hematopoietic cells: where flow meets morphology.

Authors:  Kathleen E McGrath; Timothy P Bushnell; James Palis
Journal:  J Immunol Methods       Date:  2008-05-15       Impact factor: 2.303

5.  T-bet's ability to regulate individual target genes requires the conserved T-box domain to recruit histone methyltransferase activity and a separate family member-specific transactivation domain.

Authors:  Megan D Lewis; Sara A Miller; Michael M Miazgowicz; Kristin M Beima; Amy S Weinmann
Journal:  Mol Cell Biol       Date:  2007-10-08       Impact factor: 4.272

6.  Neutrophilic granulocytes modulate invariant NKT cell function in mice and humans.

Authors:  Gerhard Wingender; Marcus Hiss; Isaac Engel; Konrad Peukert; Klaus Ley; Hermann Haller; Mitchell Kronenberg; Sibylle von Vietinghoff
Journal:  J Immunol       Date:  2012-03-02       Impact factor: 5.422

Review 7.  Transcriptional regulatory networks for CD4 T cell differentiation.

Authors:  Darah Christie; Jinfang Zhu
Journal:  Curr Top Microbiol Immunol       Date:  2014       Impact factor: 4.291

8.  IL-36γ/IL-1F9, an innate T-bet target in myeloid cells.

Authors:  Malte Bachmann; Patrick Scheiermann; Lorena Härdle; Josef Pfeilschifter; Heiko Mühl
Journal:  J Biol Chem       Date:  2012-10-24       Impact factor: 5.157

Review 9.  Roles for TNF-receptor associated factor 3 (TRAF3) in lymphocyte functions.

Authors:  Zuoan Yi; Wai Wai Lin; Laura L Stunz; Gail A Bishop
Journal:  Cytokine Growth Factor Rev       Date:  2013-12-25       Impact factor: 7.638

10.  Signal transducer and activator of transcription 4 is required for the transcription factor T-bet to promote T helper 1 cell-fate determination.

Authors:  Vivian T Thieu; Qing Yu; Hua-Chen Chang; Norman Yeh; Evelyn T Nguyen; Sarita Sehra; Mark H Kaplan
Journal:  Immunity       Date:  2008-11-14       Impact factor: 31.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.